0001179110-12-005193.txt : 20120316
0001179110-12-005193.hdr.sgml : 20120316
20120316141529
ACCESSION NUMBER: 0001179110-12-005193
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120314
FILED AS OF DATE: 20120316
DATE AS OF CHANGE: 20120316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BISARO PAUL
CENTRAL INDEX KEY: 0001237253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13305
FILM NUMBER: 12697065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WATSON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000884629
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 953872914
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: MORRIS CORPORATE CENTER III
STREET 2: 400 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 9092701400
MAIL ADDRESS:
STREET 1: MORRIS CORPORATE CENTER III
STREET 2: 400 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
4
1
edgar.xml
FORM 4 -
X0304
4
2012-03-14
0
0000884629
WATSON PHARMACEUTICALS INC
WPI
0001237253
BISARO PAUL
MORRIS CORPORATE CENTER III
400 INTERPACE PARKWAY
PARSIPPANY
NJ
07054
1
1
0
0
President & CEO
Common Stock, par value $0.0033
2012-03-14
4
F
0
6521
59.21
D
307339
D
Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.
Paul M. Bisaro
2012-03-16